First cytogenomic characterization of murine cutaneous sarcoma cell line TSC2ang1
Keywords:
murine tumor cell line, sarcoma, tuberous sclerosis, hamartomas, molecular cytogeneticsAbstract
The murine cutaneous sarcoma cell line TSC2ang1 has been established in 1999 and recently been suggested to be a model for tuberous sclerosis-associated skin lesions/ hamartomas. This suggestion was founded in first place on the fact that the cell line has been established from tumor arising in a heterozygote tsc2-gene knockout mouse. Here, as the genetic characteristics of TSC2ang1 have never been determined in detail before, chromosome microarray and multicolor banding-based molecular cytogenetics were done. A near tetraploid karyotype with 69 to 77 chromosomes per cell, and two equally sized subclones were characterized for TSC2ang1. Into the human genome translated results of identified gains and losses, and a literature review showed that TSC2ang1 is rather suited as a sarcoma model than for tuberous sclerosis-associated hamartomas.
References
Alesi, N., Akl, E.W., Khabibullin, D., Liu, H.J., Nidhiry, A.S., Garner, E.R., Filippakis, H., Lam, H.C., Shi, W., Viswanathan, S.R., Morroni, M., Ferguson-Smith, M. & Henske, E.P. (2021). TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism. Nature Communications, 12(1), 4245. https://doi.org/10.1038/ s41467-021-24499-6.
Alkharusi, A., Lesma, E., Ancona, S., Chiaramonte, E., Nyström, T., Gorio, A. & Norstedt, G. (2016). Role of prolactin receptors in lymphangioleiomyomatosis. PLoS One, 11(1), e0146653. https://doi. org/10.1371/journal.pone.0146653.
Azawi, S., Liehr, T., Rincic, M. & Manferrari, M. (2020). Molecular cytogenomic characterization of the murine breast cancer cell lines C-127I, EMT6/P and TA3 Hauschka. International Journal of Molecular Sciences, 21(13), 4716. https://doi.org /10.3390/ ijms2113471 6.
Azawi, S., Liehr, T. & Rincic, M. (2021a). First molecular cytogenetic characterization of tracheal squamous cell carcinoma cell line KLN 205. Journal of Cancer and Metastasis Treatment, 7(1), 38. https://doi. org/10.20517/2394-4722.2021.59.
Azawi S., Barf L-M. & Liehr, T. (2021b). First molecular cytogenetic characterization of the MMT 060562 murine breast cancer cell line. Research Results in Biomedicine, 7(1), 4-14. http://rrmedicine.ru/en/ journal/article/2278/.
Azawi, S., Piaszinski, K., Balachandran, M., Liehr, T. & Rincic, M. (2021c). Molecular cytogenomic characterization of two murine liver cancer cell lines: MH-22A and Hepa 1-6. Journal of Genetics and Genomes, 5(1), 1. https://www. hilarispublisher.com/open-access/ molecular-cytogenomic-characterization-of-two-murine-liver-cancercell-lines-mh22a-and-hepa-16.pdf.
Azawi, S., Rincic, M. & Liehr, T. (2021d). Cytogenomic characteristics of murine breast cancer cell line JC. Molecular Cytogenetics, 14(1), 7. https://doi.org/10.1186/s13039- 020-00524-z.
Azawi, S., Balachandran, M., Kramer, F., Kankel, S., Rincic, M. & Liehr, T. (2022). Molecular cytogenetic characterization of the urethaneinduced murine lung cell line LA-4 as a model for human squamous cell lung cancer. Molecular Clinical Oncology, 16(1), 9. https://doi.org /10.3892/mco.2021.2440.
Davoli, T. & de Lange, T. (2012). Telomeredriven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells. Cancer Cells, 21(6), 765-776. https://doi.org /10.1016 /j.ccr.2012.03.044.
Deeb, G., Baer, M.R., Gaile, D.P., Sait, S.N., Barcos, M., Wetzler, M., Conroy, J.M., Nowak, N.J., Cowell, J.K. & Cheney, R.T. (2005). Genomic profiling of myeloid sarcoma by array comparative genomic hybridization. Genes Chromosomes and Cancer, 44(4), 373-383. https:// doi.org/10.1002/gcc.20239.
European Chromosome 16 Tuberous Sclerosis Consortium . (1993). Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell, 75(7), 1305-1315.
Ferreira, R.B., Wang, M., Law, M.E., Davis, B.J., Bartley, A.N., Higgins, P.J., Kilberg, M.S., Santostefano, K.E., Terada, N., Heldermon, C.D., Castellano, R.K. & Law, B.K. (2017). Disulfide bond disrupting agents activate the unfolded protein response in EGFR-and HER2-positive breast tumor cells. Oncotarget, 8(17), 28971-28989. https://doi.org/10.18632/oncotarget.15952.
Forus, A., Weghuis, D.O., Smeets, D., Fodstad, O., Myklebost, O. & van Kessel, A.G. (1995). Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21- q22 in soft tissue sarcomas. Genes Chromosomes and Cancer, 14(1), 8-14. https://doi.org /10.1002/ gcc.2870140103.
Gao, Y., Gartenhaus, R.B., Lapidus, R.G., Hussain, A., Zhang, Y., Wang, X. & Dan, H.C. (2015). Differential IKK/NF-κB activity is mediated by TSC2 through mTORC1 in PTEN-null prostate cancer and tuberous sclerosis complex tumor cells. Molecular Cancer Research, 13(12), 1602-1614. https://doi.org /10.1158/1541-7786.mcr-15-0213.
Govindarajan, B., Willoughby, L., Band, H., Curatolo, A.S., Veledar, E., Chen, S., Bonner M.Y., Abel, M.G., Moses, M.A. & Arbiser, J.L. (2012). Cooperative benefit for the combination of rapamycin and imatinib in tuberous sclerosis complex neoplasia. Vascular Cell, 4(1), 11. https://doi.org /10.1186 /2045-824x-4-11.
Guja, K., Liehr, T., Rincic, M., Kosyakova, N. & Azawi, S.S.H. (2017). Molecular cytogenetic characterization identified the murine B-cell lymphoma cell line A-20 as a model for sporadic Burkitt’s lymphoma. Journal of Histochemistry and Cytochemistry, 65(11), 669- 677. https://doi.org /10.1369/ 0022155417731319.
Kubicova, E., Trifonov, V., Borovecki, F., Liehr, T., Rincic, M., Kosyakova, N. & Hussein, S.S. (2017). First molecular cytogenetic characterization of murine malignant mesothelioma cell line AE17 and in silico translation to the human genome. Current Bioinformatics, 12(1), 11-18. http://dx.doi.org/ 10.2174 /1574893611666160606164459.
Leibiger, C., Kosyakova, N., Mkrtchyan, H., Glei, M., Trifonov, V. & Liehr, T. (2013). First molecular cytogenetic high resolution characterization of the NIH 3T3 cell line by murine multicolor banding. Journal of Histochemistry and Cytochemistry, 61(4), 306-312. https://doi.org /10.1369/0022155413476868.
Luo, C, Ye, W. R., Shi, W., Yin, P., Chen, C., He, Y.B., Chen, M .F., Zu, X.B. & Cai, Y. (2022). Perfect match: mTOR inhibitors and tuberous sclerosis complex. Orphanet Journal of Rare Diseases, 17(1), 106. https://doi.org/10.1186/ s13023-022-02266-0.
Manferrari, M., Rincic, M., Liehr, T. & Azawi, S. (2020). Cytogenomics of murine melanoma cell lines C57/ B1 and B16-F0. Molecular and Experimental Biology in Medicine, 3(2), 39-44. https://hrcak.srce.hr/ file/380456.
Mihic-Probst, D., Zhao, J., Saremaslani, P., Baer, A., Oehlschlegel, C., Paredes, B., Komminoth, P. & Heitz, P.U. (2004). CGH analysis shows genetic similarities and differences in atypical fibroxanthoma and undifferentiated high grade pleomorphic sarcoma. Anticancer Research, 24(1), 19-26. https://ar.iiarjournals.org/content/ anticanres/24/1/19.full.pdf.
Onda, H., Lueck, A., Marks, P.W., Warren, H. B. & Kwiatkowski, D.J. (1999). Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. Journal of Clinical Investigations, 104(6), 687-695. https://doi.org/10.1172/jci7319.
Piaszinski, K., Rincic, M., Liehr, T. & Azawi, S. (2021). Molecular cytogenetic characterization of the murine melanoma cell lines S91 clone M3 and B16-F1 with variant B16-4A5. Cytogenetics and Genome Research, 161(1-2), 82-92. https:// doi.org/10.1159/000513174.
Rhode, H., Liehr, T., Kosyakova, N., Rinčic, M. & Azawi, S.S.H. (2018). Molecular cytogenetic characterization of two murine colorectal cancer cell lines. OBM Genetics, 2(3), 1803037. http://dx.doi.org/10.21926/ obm.genet.1803037.
Steinacker, R., Liehr, T., Kosyakova, N., Rincic, M. & Azawi, S.S.H. (2019). Molecular cytogenetic characterization of two murine cancer cell lines derived from salivary gland. Biological Communications, 63(4), 243-255. https://doi.org/10.21638/ spbu03.2018.403.
Swarbrick, A. W., Frederiks, A.J. & Foster, R.S. (2021). Systematic review of sirolimus in dermatological conditions. Australasian Journal of Dermatology, 62(4), 461-469. https://doi.org/10.1111/ajd.13671.
Van Slegtenhorst, M., de Hoogt, R., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., van den Ouweland, A., Halley, D., Young, J., Burley, M., Jeremiah, S., Woodward, K., Nahmias, J., Fox, M., Ekong, R., Osborne, J., Wolfe, J., Povey, S., Snell, R.G., Cheadle, J.P., Jones, A.C., Tachataki, M., Ravine, D., Sampson, J.R., Reeve, M.P., Richardson, P., Wilmer, F., Munro, C., Hawkins, T.L., Sepp, T., Ali, J.B., Ward, S., Green, A. J., Yates, J.R., Kwiatkowska, J., Henske, E.P., Short, M.P., Haines, J.H., Jozwiak, S. & Kwiatkowski, D.J. (1997). Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277(5327), 805-808. https://doi. org/10.1126/science.277.5327.805.
Wahlbuhl, E., Liehr, T., Rincic, M. & Azawi, S. (2020). Cytogenomic characterization of three murine malignant mesothelioma tumor cell lines. Molecular Cytogenetics, 13(1), 43. https://doi.org/10.1186/ s13039-020-00511-4.
Wlodarski, P.K., Maksym, R., Oldak, M., Jozwiak, S., Wojcik, A., & Jozwiak, J. (2008). Tuberin-heterozygous cell line TSC2ang1 as a model for tuberous sclerosis-associated skin lesions. International Journal of Molecular Medicine, 21(2), 245-250. https://doi.org/10.3892 /ijmm.21.2.245.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Science Technology and Engineering Journal (STEJ)
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
